Paper9105597
In vitro and in vivo degradation of films of chitin and its deacetylated derivatives.
Tomihata K and 1 other. Biomaterials, 1997. Cited by 471 papers, by iCite.
Cite this record
ConductScience Library. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Papers, record 9105597. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9105597
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chitin | Major topic |
| Acetylation | |
| Animals | |
| Biotransformation | |
| Chitosan | |
| Hydrolysis | |
| Kinetics | |
| Muramidase | |
| Rats | |
| Rats, Wistar | |
| Sodium Hydroxide | |
| Tensile Strength | |
| Water |
Source PubMed
Cited by121
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 471 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42599883 | Comparative efficacy of nerve coagulation vs. cap implantation in neuroma prevention using the rat sciatic nerve model: A histological and neuroradiological insight. | PLoS One | 2026 | https://conductscience.org/library/papers/42599883 | PubMed |
| 42253852 | The Pivotal Step of Structure Formation and Oil-Binding Capacity of Polyglucosamine. | Polym Sci Technol | 2026 | https://conductscience.org/library/papers/42253852 | PubMed |
| 41590821 | Fibrous Biomaterial Scaffold for Tympanic Membrane Repair: Microarchitectural Engineering and Structure Function Performance. | J Funct Biomater | 2026 | https://conductscience.org/library/papers/41590821 | PubMed |
| 40657196 | Biodegradable Piezoelectric Micro- and Nanomaterials for Regenerative Medicine, Targeted Therapy, and Microrobotics. | Small Sci | 2025 | https://conductscience.org/library/papers/40657196 | PubMed |
| 40300853 | Hermetia illucens-Derived Chitosan: A Promising Immunomodulatory Agent for Applications in Biomedical Fields. | Biomacromolecules | 2025 | https://conductscience.org/library/papers/40300853 | PubMed |
| 39866778 | Matrix vesicle-inspired delivery system based on nanofibrous chitosan microspheres for enhanced bone regeneration. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/39866778 | PubMed |
| 39583848 | Stability, challenges, and prospects of chitosan for the delivery of anticancer drugs and tissue regenerative growth factors. | Heliyon | 2024 | https://conductscience.org/library/papers/39583848 | PubMed |
| 39061802 | Chitosan Scaffolds from Crustacean and Fungal Sources: A Comparative Study for Bone-Tissue-Engineering Applications. | Bioengineering (Basel) | 2024 | https://conductscience.org/library/papers/39061802 | PubMed |
| 38931897 | Design of Chitin Cell Culture Matrices for 3D Tissue Engineering: The Importance of Chitin Types, Solvents, Cross-Linkers, and Fabrication Techniques. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38931897 | PubMed |
| 38921188 | Synthesis of Chitosan and Ferric-Ion (Fe3+)-Doped Brushite Mineral Cancellous Bone Scaffolds. | Biomimetics (Basel) | 2024 | https://conductscience.org/library/papers/38921188 | PubMed |
| 38887635 | Chitosan alchemy: transforming tissue engineering and wound healing. | RSC Adv | 2024 | https://conductscience.org/library/papers/38887635 | PubMed |
| 38532906 | Enhanced Postsurgical Cancer Treatment Using Methacrylated Glycol Chitosan Hydrogel for Sustained DNA/Doxorubicin Delivery and Immunotherapy. | Biomater Res | 2024 | https://conductscience.org/library/papers/38532906 | PubMed |
| 38268700 | Investigation of Roughness, Morphology, and Wettability Characteristics of Biopolymer Composite Coating on SS 316L for Biomedical Applications. | Int J Biomater | 2024 | https://conductscience.org/library/papers/38268700 | PubMed |
| 38168144 | Comparison of the differentiation of ovine fetal bone-marrow mesenchymal stem cells towards osteocytes on chitosan/alginate/CuO-NPs and chitosan/alginate/FeO-NPs scaffolds. | Sci Rep | 2024 | https://conductscience.org/library/papers/38168144 | PubMed |
| 37920452 | Molecularly Tailored Interface for Long-Term Xenogeneic Cell Transplantation. | Adv Funct Mater | 2022 | https://conductscience.org/library/papers/37920452 | PubMed |
| 37896373 | Bactericidal Activity of Silver-Doped Chitosan Coatings via Electrophoretic Deposition on Ti6Al4V Additively Manufactured Substrates. | Polymers (Basel) | 2023 | https://conductscience.org/library/papers/37896373 | PubMed |
| 37488180 | Schwann cell-encapsulated chitosan-collagen hydrogel nerve conduit promotes peripheral nerve regeneration in rodent sciatic nerve defect models. | Sci Rep | 2023 | https://conductscience.org/library/papers/37488180 | PubMed |
| 37241924 | Sustainable Phenylalanine-Derived SAILs for Solubilization of Polycyclic Aromatic Hydrocarbons. | Molecules | 2023 | https://conductscience.org/library/papers/37241924 | PubMed |
| 37235849 | Biodegradable Piezoelectric Polymers: Recent Advancements in Materials and Applications. | Adv Healthc Mater | 2023 | https://conductscience.org/library/papers/37235849 | PubMed |
| 35563158 | Pure Chitosan Biomedical Textile Fibers from Mixtures of Low- and High-Molecular Weight Bidisperse Polymer Solutions: Processing and Understanding of Microstructure-Mechanical Properties' Relationship. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563158 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9105597
GET https://conductscience.org/api/papers/v1/9105597/cited_by?page=2